| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |